adrenaline (epinephrine) acid tartrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
4% Articadent DENTAL with adrenaline (epinephrine) 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 2.2 mL injection cartridge
AUST R: 231745
Active ingredients:
adrenaline (epinephrine) acid tartrate
articaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Dentsply Sirona Pty Ltd

Phone:
1300552929

From
25 Aug 2025
to
30 Sep 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Transport / Logistic issues / Storage capacity issues
XYLOCAINE 2% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12021
Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
12 Sep 2025
to
10 Oct 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing
BUPIVADREN Bupivacaine 0.25% w/v with Adrenaline (epinephrine) 1:400,000 injection solution vial
AUST R: 292526
Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Sep 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic product is available.
BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial
AUST R: 292528
Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Sep 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.